Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06440525 | RECRUITING | Primary Sjögren Syndrome

A Study of RSLV-132 in Females With Sjögren's Syndrome
Sponsor:

Resolve Therapeutics

Brief Summary:

The goal of this clinical study is to learn if RSLV-132 improves the symptoms of SS in adults. It will also learn about the safety of RSLV-132. The main questions it aims to answer are: * Does RSLV-132 improve the cardinal symptoms of Sjogren's including fatigue, dryness and pain? * Does RSLV-132 improve the tiredness/fatigue caused by Sjogren's? * What are the blood levels of RSLV-132 over time? * What is the immune (antibody) response in the body to RSLV-132? * What is the safety profile of RSLV-132? Researchers will compare RSLV-132 to a placebo (a look-alike substance that contains no drug) to see if RSLV-132 improves the symptoms of pSS. Participants will: Take RSLV-132 or a placebo 13 times over 22 weeks Visit the clinic once every week for the first 2 weeks, then every 2 weeks until the end of treatment and then for a final time 4 weeks later (Day 211) for check-ups, tests and to answer questionnaires about their symptoms Record their symptoms every day on an electronic device

Condition or disease

Primary Sjögren syndrome

Intervention/treatment

RSLV-132

Placebo

Phase

PHASE2

Study Type : INTERVENTIONAL
Estimated Enrollment : 106 participants
Masking : QUADRUPLE
Primary Purpose : TREATMENT
Official Title : A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Impact of Intravenous RSLV-132 in Participants With Sjögren's Syndrome (pSS) With Moderate to Severe Symptom Burden
Actual Study Start Date : 2024-09-01
Estimated Primary Completion Date : 2026-05-01
Estimated Study Completion Date : 2026-07-01

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years to 65 Years
Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Providing written informed consent
  • * Weight at least 45 kg
  • * Meet the 2016 American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) Classification Criteria for pSS
  • * Diagnosis in the last 10 years
  • * Positive anti-Ro/SSA antibody test
  • * Score of 5 or higher on the EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI) scale and the ESSPRI fatigue scale
  • * Of non childbearing potential or of childbearing potential and using highly effective contraceptive measures
Exclusion Criteria
  • * Diagnosis of any active autoimmune disease other than pSS that could affect the efficacy assessments
  • * Uncontrolled hypothyroidism or severe fibromyalgia
  • * New medications or change in medications in the last 4 weeks for pSS symptoms
  • * Receipt of other prohibited medications
  • * Apheresis or blood donation
  • * Allergic reaction to RSLV-132 or biologic therapy
  • * Clinically significant infection in last 30 days
  • * Participation in another clinical study
  • * Malignancy in last 5 years
  • * Positive test for HIV or hepatitis
  • * Major surgery in last 30 days or anticipated surgery during the study
  • * Pregnancy or breast feeding
  • * Laboratory blood tests outside of specified ranges
  • * Other medical conditions or medications that would make the participant unsuitable
A Study of RSLV-132 in Females With Sjögren's Syndrome

Location Details

NCT06440525

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

RECRUITING

United States, California

Resolve Clinical Site

Chula Vista, California, United States, 91910

RECRUITING

United States, Florida

Resolve Clinical Site

Boca Raton, Florida, United States, 34994

RECRUITING

United States, Florida

Resolve Clinical Site

Boynton Beach, Florida, United States, 33467

RECRUITING

United States, Florida

Evolution Research Center

Hialeah, Florida, United States, 33024

RECRUITING

United States, Florida

GNP Research

Hollywood, Florida, United States, 33024

RECRUITING

United States, Florida

Life Medical Research

Miami Gardens, Florida, United States, 33014

RECRUITING

United States, Florida

Resolve Clinical Site

Miami, Florida, United States, 33140

RECRUITING

United States, Illinois

Resolve Clinical Site

Chicago, Illinois, United States, 60607

RECRUITING

United States, Massachusetts

Tufts College

Boston, Massachusetts, United States, 02111-1817

RECRUITING

United States, New Mexico

Resolve Clinical Site

Albuquerque, New Mexico, United States, 87106

RECRUITING

United States, North Carolina

Joint and Muscle Research Institute

Charlotte, North Carolina, United States, 28204

RECRUITING

United States, North Carolina

Arthritis and Osteoporosis Consultants of the Carolinas

Charlotte, North Carolina, United States, 28208

RECRUITING

United States, North Carolina

Onsite Clinical Solutions

Salisbury, North Carolina, United States, 28277

RECRUITING

United States, Pennsylvania

Altoona Center for Clinical Research

Duncansville, Pennsylvania, United States, 16635

RECRUITING

United States, Texas

Resolve Clinical Site

Katy, Texas, United States, 77449

RECRUITING

United States, Texas

Resolve Clinical Site

McKinney, Texas, United States, 75069

RECRUITING

United States, Texas

Accurate Clinical Research

Richmond, Texas, United States, 77089

RECRUITING

United States, Texas

Resolve Clinical Site

San Antonio, Texas, United States, 78215

RECRUITING

United States, Utah

Metrodora Institute

Salt Lake City, Utah, United States, 84119

RECRUITING

United States, Washington

Arthritis Northwest

Spocane, Washington, United States, 99204